Mechanisms underlying the localisation of mast cells in tissues

Trends in Immunology

Volumn 32, Issue 10, 2011, Pages 478-485

  Collington, Sarah J ^a   Williams, Timothy J ^b   Weller, Charlotte L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Norvartis Institute for BioMedical Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CELL ADHESION MOLECULE; CHEMOATTRACTANT; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR4; EOTAXIN; EOTAXIN 2; EOTAXIN 3; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 5; INTERLEUKIN 8; INTERLEUKIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; RANTES; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGY; BONE MARROW CELL; CELL MATURATION; CYTOKINE PRODUCTION; DOWN REGULATION; HELMINTHIASIS; HOST RESISTANCE; HUMAN; INFLAMMATORY DISEASE; MAST CELL; NONHUMAN; REVIEW; TISSUE DISTRIBUTION; UPREGULATION; WOUND HEALING;

ANIMALS; BONE MARROW CELLS; CELL ADHESION MOLECULES; CELL MOVEMENT; CELLULAR MICROENVIRONMENT; CHEMOKINES; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; IMMUNOGLOBULIN E; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAST CELLS; MICE; NEMATODA; NEMATODE INFECTIONS; RECEPTORS, CHEMOKINE; SIGNAL TRANSDUCTION;

EID: 80053305349     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2011.08.002     Document Type: Review

References (92)

1. Weller C.L., et al. Mast cells in health and disease. Clin. Sci. (Lond.) 2011, 120:473-484.
2. Ha T.Y., et al. Delayed expulsion of adult Trichinella spiralis by mast cell-deficient W/Wv mice. Infect. Immun. 1983, 41:445-447.
3. Lawrence C.E., et al. Mouse mast cell protease-1 is required for the enteropathy induced by gastrointestinal helminth infection in the mouse. Gastroenterology 2004, 127:155-165.
4. Galli S.J., Tsai M. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. Eur. J. Immunol. 2010, 40:1843-1851.
5. Ali H. Regulation of human mast cell and basophil function by anaphylatoxins C3a and C5a. Immunol. Lett. 2010, 128:36-45.
6. Weller C.L., et al. Leukotriene B4, an activation product of mast cells, is a chemoattractant for their progenitors. J. Exp. Med. 2005, 201:1961-1971.
7. Ali K., et al. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 2004, 431:1007-1011.
8. Koyasu S., et al. The role of phosphoinositide-3-kinase in mast cell homing to the gastrointestinal tract. Novartis Found. Symp. 2005, 271:152-161. (discussion 161-165, 198-199).
9. Holgate S., et al. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J. Allergy Clin. Immunol. 2005, 115:459-465.
10. Ley K., et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
11. Martin C., et al. Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 2003, 19:583-593.
12. Palframan R.T., et al. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow. Blood 1998, 91:2240-2248.
13. Wengner A.M., et al. The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation. Blood 2008, 111:42-49.
14. Teixeira M.M., et al. Chemokine-induced eosinophil recruitment. Evidence of a role for endogenous eotaxin in an in vivo allergy model in mouse skin. J. Clin. Invest. 1997, 100:1657-1666.
15. Jamur M.C., et al. Identification and characterization of undifferentiated mast cells in mouse bone marrow. Blood 2005, 105:4282-4289.
16. Chen C.C., et al. Identification of mast cell progenitors in adult mice. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:11408-11413.
17. Franco C.B., et al. Distinguishing mast cell and granulocyte differentiation at the single-cell level. Cell Stem Cell 2010, 6:361-368.
18. Austen K.F., Boyce J.A. Mast cell lineage development and phenotypic regulation. Leuk. Res. 2001, 25:511-518.
19. Jamur M.C., Oliver C. Origin, maturation and recruitment of mast cell precursors. Front. Biosci. (Schol. Ed.) 2011, 3:1390-1406.
20. Ochi H., et al. T helper cell type 2 cytokine-mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J. Exp. Med. 1999, 190:267-280.
21. Galli S.J., et al. The development of allergic inflammation. Nature 2008, 454:445-454.
22. Lee K.S., et al. Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis. Am. J. Respir. Crit. Care Med. 2008, 178:787-797.
23. Jiang W., et al. Mast cells drive mesenteric afferent signalling during acute intestinal ischemia. J. Physiol. 2011, 589(Pt 15):3867-3882.
24. Li E., et al. Mast cell-mediated changes in smooth muscle contractility during mouse giardiasis. Infect. Immun. 2007, 75:4514-4518.
25. Hamid Q., Tulic M. Immunobiology of asthma. Annu. Rev. Physiol. 2009, 71:489-507.
26. Bradding P., et al. The role of the mast cell in the pathophysiology of asthma. J. Allergy Clin. Immunol. 2006, 117:1277-1284.
27. Buhner S., Schemann M. Mast cell-nerve axis with a focus on the human gut. Biochim. Biophys. Acta 2011, Jun 17. [Epub ahead of print]; PMID:21704703.
28. Oliveira S.H., et al. Neutrophil migration induced by IL-1beta depends upon LTB4 released by macrophages and upon TNF-alpha and IL-1beta released by mast cells. Inflammation 2008, 31:36-46.
29. Ribeiro R.A., et al. Role of resident mast cells and macrophages in the neutrophil migration induced by LTB4, fMLP and C5a des arg. Int. Arch. Allergy Immunol. 1997, 112:27-35.
30. Ott V.L., et al. Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. Nat. Immunol. 2003, 4:974-981.
31. Das A.M., et al. Eotaxin-induced eosinophil migration in the peritoneal cavity of ovalbumin-sensitized mice: mechanism of action. J. Immunol. 1997, 159:1466-1473.
32. Reuter S., et al. Mast cells induce migration of dendritic cells in a murine model of acute allergic airway disease. Int. Arch. Allergy Immunol. 2010, 151:214-222.
33. Dudeck A., et al. Mast cells promote Th1 and Th17 responses by modulating dendritic cell maturation and function. Eur. J. Immunol. 2011, 41:1883-1893.
34. Dawicki W., Marshall J.S. New and emerging roles for mast cells in host defence. Curr. Opin. Immunol. 2007, 19:31-38.
35. Kulka M., et al. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol. 2004, 114:174-182.
36. McCurdy J.D., et al. Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol. 2003, 170:1625-1629.
37. Miller H.R., Pemberton A.D. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 2002, 105:375-390.
38. Pejler G., et al. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 2010, 115:4981-4990.
39. Heavey D.J., et al. Generation of leukotriene C4, leukotriene B4, and prostaglandin D2 by immunologically activated rat intestinal mucosa mast cells. J. Immunol. 1988, 140:1953-1957.
40. Balzar S., et al. Mast Cell Phenotype, Location and Activation in Severe Asthma. Data from The Severe Asthma Research Program. Am. J. Respir. Crit. Care Med. 2011, 183:299-309.
41. Friend D.S., et al. Reversible expression of tryptases and chymases in the jejunal mast cells of mice infected with Trichinella spiralis. J. Immunol. 1998, 160:5537-5545.
42. Zarbock A., Ley K. Neutrophil adhesion and activation under flow. Microcirculation 2009, 16:31-42.
43. Borregaard N. Neutrophils, from marrow to microbes. Immunity 2010, 33:657-670.
44. Dudeck A., et al. Immature mast cells exhibit rolling and adhesion to endothelial cells and subsequent diapedesis triggered by E- and P-selectin, VCAM-1 and PECAM-1. Exp. Dermatol. 2010, 19:424-434.
45. Gurish M.F., et al. Intestinal mast cell progenitors require CD49dbeta7 (alpha4beta7 integrin) for tissue-specific homing. J. Exp. Med. 2001, 194:1243-1252.
46. Abonia J.P., et al. Alpha-4 integrins and VCAM-1, but not MAdCAM-1, are essential for recruitment of mast cell progenitors to the inflamed lung. Blood 2006, 108:1588-1594.
47. Hallgren J., et al. Pulmonary CXCR2 regulates VCAM-1 and antigen-induced recruitment of mast cell progenitors. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:20478-20483.
48. Berlanga O., et al. GPIIb (CD41) integrin is expressed on mast cells and influences their adhesion properties. Exp. Hematol. 2005, 33:403-412.
49. Rosenkranz A.R., et al. Impaired mast cell development and innate immunity in Mac-1 (CD11b/CD18, CR3)-deficient mice. J. Immunol. 1998, 161:6463-6467.
50. Brown J.K., et al. Expression of integrin-alphaE by mucosal mast cells in the intestinal epithelium and its absence in nematode-infected mice lacking the transforming growth factor-beta1-activating integrin alphavbeta6. Am. J. Pathol. 2004, 165:95-106.
51. Palframan R.T., et al. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase. J. Exp. Med. 1998, 188:1621-1632.
52. Taub D., et al. Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J. Immunol. 1995, 154:2393-2402.
53. Lippert U., et al. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells. J. Immunol. 1998, 161:2600-2608.
54. Nilsson G., et al. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB. Blood 1999, 93:2791-2797.
55. El-Shazly A., et al. Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma. J. Immunol. 2006, 176:1860-1868.
56. Juremalm M., et al. The chemokine receptor CXCR4 is expressed within the mast cell lineage and its ligand stromal cell-derived factor-1alpha acts as a mast cell chemotaxin. Eur. J. Immunol. 2000, 30:3614-3622.
57. Gurish M.F., et al. CCR3 is required for tissue eosinophilia and larval cytotoxicity after infection with Trichinella spiralis. J. Immunol. 2002, 168:5730-5736.
58. Humbles A.A., et al. The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:1479-1484.
59. Collington S.J., et al. The function of CCR3 on mouse bone marrow-derived mast cells in vitro. Immunology 2010, 129:115-124.
60. Miyazaki D., et al. Ablation of type I hypersensitivity in experimental allergic conjunctivitis by eotaxin-1/CCR3 blockade. Int. Immunol. 2009, 21:187-201.
61. Quackenbush E.J., et al. Eotaxin influences the development of embryonic hematopoietic progenitors in the mouse. J. Leukoc. Biol. 1997, 62:661-666.
62. Quackenbush E.J., et al. Eotaxin modulates myelopoiesis and mast cell development from embryonic hematopoietic progenitors. Blood 1998, 92:1887-1897.
63. Collington S.J., et al. The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo. J. Immunol. 2010, 184:6114-6123.
64. Ruschpler P., et al. High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res. Ther. 2003, 5:R241-R252.
65. Brightling C.E., et al. Mast-cell infiltration of airway smooth muscle in asthma. N. Engl. J. Med. 2002, 346:1699-1705.
66. Brightling C.E., et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am. J. Respir. Crit. Care Med. 2005, 171:1103-1108.
67. Buckland K.F., et al. Histamine induces cytoskeletal changes in human eosinophils via the H(4) receptor. Br. J. Pharmacol. 2003, 140:1117-1127.
68. Godot V., et al. H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. J. Allergy Clin. Immunol. 2007, 120:827-834.
69. Belot M.P., et al. Progesterone reduces the migration of mast cells toward the chemokine stromal cell-derived factor-1/CXCL12 with an accompanying decrease in CXCR4 receptors. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E1410-E1417.
70. Carroll N.G., et al. Increased mast cells and neutrophils in submucosal mucous glands and mucus plugging in patients with asthma. Thorax 2002, 57:677-682.
71. Balzar S., et al. Mast cell phenotype, location, and activation in severe asthma: data from the severe asthma research program. Am. J. Respir. Crit. Care Med. 2011, 183:299-309.
72. Pipkorn U., et al. Phenotypic expression of proteoglycan in mast cells of the human nasal mucosa. Histochem. J. 1988, 20:519-525.
73. Fokkens W.J., et al. Dynamics of mast cells in the nasal mucosa of patients with allergic rhinitis and non-allergic controls: a biopsy study. Clin. Exp. Allergy 1992, 22:701-710.
74. Nouri-Aria K.T., et al. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy. J. Allergy Clin. Immunol. 2005, 116:73-79.
75. Weller C.L., et al. Chemotactic action of prostaglandin E2 on mouse mast cells acting via the PGE2 receptor 3. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:11712-11717.
76. Kuehn H.S., et al. Btk-dependent Rac activation and actin rearrangement following FcepsilonRI aggregation promotes enhanced chemotactic responses of mast cells. J. Cell. Sci. 2010, 123(Pt 15):2576-2585.
77. Duffy S.M., et al. Engagement of the EP2 prostanoid receptor closes the K+ channel KCa3.1 in human lung mast cells and attenuates their migration. Eur. J. Immunol. 2008, 38:2548-2556.
78. Piliponsky A.M., et al. Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am. J. Pathol. 2010, 176:926-938.
79. Tsai M., et al. Using mast cell knock-in mice to analyze the roles of mast cells in allergic responses in vivo. Chem. Immunol. Allergy 2005, 87:179-197.
80. Meininger C.J., et al. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 1992, 79:958-963.
81. Nilsson G., et al. Stem cell factor is a chemotactic factor for human mast cells. J. Immunol. 1994, 153:3717-3723.
82. Terashima Y., et al. Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis. Nat. Immunol. 2005, 6:827-835.
83. Belema-Bedada F., et al. Efficient homing of multipotent adult mesenchymal stem cells depends on FROUNT-mediated clustering of CCR2. Cell. Stem Cell. 2008, 2:566-575.
84. Alcaide P., et al. Dendritic cell expression of the transcription factor T-bet regulates mast cell progenitor homing to mucosal tissue. J. Exp. Med. 2007, 204:431-439.
85. Jones T.G., et al. Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells. J. Immunol. 2009, 183:5251-5260.
86. Jones T.G., et al. T regulatory cells control antigen-induced recruitment of mast cell progenitors to the lungs of C57BL/6 mice. J. Immunol. 2010, 185:1804-1811.
87. Kalesnikoff J., Galli S.J. New developments in mast cell biology. Nat. Immunol. 2008, 9:1215-1223.
88. Lin T.J., Befus A.D. Differential regulation of mast cell function by IL-10 and stem cell factor. J. Immunol. 1997, 159:4015-4023.
89. Arock M., et al. Interleukin-10 inhibits cytokine generation from mast cells. Eur. J. Immunol. 1996, 26:166-170.
90. Pietrzak A., et al. Interleukin (IL)-10 inhibits RANTES-, tumour necrosis factor (TNF)- and nerve growth factor (NGF)-induced mast cell migratory response but is not a mast cell chemoattractant. Immunol. Lett. 2009, 123:46-51.
91. Tsai M., et al. Mast cells and immunoregulation/immunomodulation. Adv. Exp. Med. Biol. 2011, 716:186-211.
92. Shelburne C.P., Abraham S.N. The mast cell in innate and adaptive immunity. Adv. Exp. Med. Biol. 2011, 716:162-185.